Detection of emerging HIV variants in blood donors from urban areas of Cameroon

AIDS Research and Human Retroviruses

Volumn 23, Issue 10, 2007, Pages 1262-1267

  Lee, S ^a   Wood, O ^a   Tang, S ^a   Hu, J ^a   Machuca, A ^a   Kerby, S ^a   Awazi, B ^b   Vockley, C ^a   Hewlett, I ^a,c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Sanitation and Hygiene   (Cameroon)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; BLOOD BANK; BLOOD DONOR; CAMEROON; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; PLASMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNITED STATES; URBAN AREA; VIRUS DETECTION; VIRUS STRAIN; WESTERN BLOTTING;

AIDS SERODIAGNOSIS; BLOOD BANKS; BLOOD DONORS; BLOTTING, WESTERN; CAMEROON; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VARIATION (GENETICS); VIRAL LOAD;

EID: 35548981815     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0301     Document Type: Article

References (23)

1. Strong DM and Katz L: Blood-bank testing for infectious diseases: How safe is blood transfusion? Trends Mol Med 2002;8:355-358.
2. Update: Serologic testing for HIV-1 antibody-United States, 1988 and 1989. MMWR Morb Mortal Wkly Rep 1990;39:380-383.
3. Petersen LR, Satten GA, Dodd R, et al.: Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion 1994;34(4):283-289.
4. Phelps R, Robbins K, Liberti T, et al.: Window period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004;44:929-933.
5. Daar ES, Moudgil T, Meyer RD, and Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324(14):961-964.
6. Kahn JO and Walker BD: Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339(1):33-39.
7. Schacker TW, Hughes JP, Shea T, Coombs RW, and Corey L: Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998;128(8):613-620.
8. Busch MP, Stramer SL, Kleinman SH, et al.: Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives. Presented at a workshop during the 50th Annual Meeting of the AABB, October 1997, Denver, CO.
9. Henrard DR, Phillips J, Windsor I, et al.: Detection of human immunodeficiency virus type 1 p24 antigen and plasma and plasma RNA: Relevance to indeterminate serologic test. Transfusion 1994;34:376-380.
10. Soriano V, Dronda F, González-Lopez A, et al.: HIV-1 causes AIDS and death in a seronegative individual (letter). Vox Sang 1994;67:410-411.
11. Center for Disease Control and Prevention: Persistent lack of detectable HIV-1 antibody in a person with HIV-1 infection - Utah, 1995. MMWR 1996;45:181-185.
12. Burin des Roziers N, Coste J, Courouce A, Bibollet-Ruche F, Guillard A, and Nasr O: Detection of HIV-1 RNA in two consecutive blood donations screened negative for HIV antibodies. Vox Sang 1998;75(4):298-302.
13. Heyndrickx L, Janssens W, Ndumbe PM, et al.: HIV-1 genetic variability in Cameroon. AIDS 2000;14(12):1862-1864.
14. Nyambi P, Heyndrickx L, Vereecken K, et al.: Predominance of infection with circulating recombinant CRF02_AG in major Cameroonian cities and towns AIDS 2002;16(2):295-296.
15. Mboudjeka I, Bikandou B, Zekeng L, et al.: Genetic diversity of HIV-1 group M from Cameroon and Republic of Congo. Arch Virol 1999;144(12):2291-2311.
16. Gao F: Detection of HIV-2 by PCR. Methods Mol Biol 2005;304:191-200.
17. Machuca A, Tang S, Hu J, et al.: Increased genetic diversity and intersubtype recombinants of human immunodeficiency virus type 1 in blood donors from urban Cameroon. J Acquir Immune Defic Syndr 2007;45:361-363.
18. Sears JK and Khan A: Single-tube fluorescent product-enhanced reverse transcriptase assay with Ampliwax (STF-PERT) for retrovirus quantitation. J Virol Methods 2003;108:139-142.
19. Wolfe ND, Heneine W, Carr JK, et al.: Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 2005;102:7994-7999.
20. Busch MP, Lee LL, Satten GA, et al.: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995;35(2):91-97.
21. Kaptue L, Zekeng L, Ngu K, et al.: First case of HIV-1/HIV-2 infection in Cameroon. International Conference on AIDS, June 4-9, 1989. Abstract no. 573.
22. Sides TL, Akinsete O, Henry K, et al.: HIV-1 subtype diversity in Minnesota. J Infect Dis 2005;192:37-45.
23. Laeyendecker O, Li X, Arroyo M, et al.: The effect of HIV subtype on rapid disease progression in Rakai, Uganda. Presented during the 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO., February 5-8, 2006.